Biogen (NASDAQ:BIIB) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Biogen announced earnings per share of $5.68 on revenue of $2.78B. Analysts polled by Investing.com anticipated EPS of $4.6 on revenue of $2.61B.
Biogen shares are up 31% from the beginning of the year, still down 31.02% from its 52 week high of $468.20 set on June 7. They are outperforming the Nasdaq 100 which is up 15.16% from the start of the year.
https://www.investing.com/news/stock-market-news/biogen-earnings-revenue-beat-in-q2-2565084
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.